Prognostic impact and potential interaction of EGFR and c-Met in the progression of esophageal squamous cell carcinoma

The prognostic value of EGFR overexpression and amplification in Esophageal squamous cell Carcinoma

(2015) Dongxian Jiang et al.   BMC CANCER

Expression and clinical significance of c-Met in advanced esophageal squamous cell carcinoma

(2015) Yingying Xu et al.   BMC CANCER

Targeted therapy in first line treatment of RAS wild type colorectal cancer

(2015) Vincenzo Formica   WORLD JOURNAL OF GASTROENTEROLOGY

HER2-directed therapy: current treatment options for HER2-positive breast cancer

(2015) Shahid Ahmed et al.   Breast Cancer

Phase II study of neoadjuvant therapy with docetaxel, cisplatin, panitumumab, and radiation therapy followed by surgery in patients with locally advanced adenocarcinoma of the distal esophagus (ACOSOG Z4051)†

(2014) A. C. Lockhart et al.   ANNALS OF ONCOLOGY

Global incidence of oesophageal cancer by histological subtype in 2012

(2014) Melina Arnold et al.   GUT

Frequent hepatocyte growth factor overexpression and low frequency of c-Met gene amplification in human papillomavirus–negative tonsillar squamous cell carcinoma and their prognostic significances

(2014) Mi Jung Kwon et al.   HUMAN PATHOLOGY

c-Met Expression Is a Marker of Poor Prognosis in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Treated With Chemoradiation

(2014) Andrew M. Baschnagel et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

A Prospective, Molecular Epidemiology Study of EGFR Mutations in Asian Patients with Advanced Non–Small-Cell Lung Cancer of Adenocarcinoma Histology (PIONEER)

(2014) Yuankai Shi et al.   Journal of Thoracic Oncology

MET Expression Plays Differing Roles in Non–Small-Cell Lung Cancer Patients with or without EGFR Mutation

(2014) Ling Huang et al.   Journal of Thoracic Oncology

Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial

(2014) Susan J Dutton et al.   LANCET ONCOLOGY

Identification of genomic alterations in oesophageal squamous cell cancer

(2014) Yongmei Song et al.   NATURE

Genentech to salvage anti-MET antibody with subgroup analysis

(2014) Cormac Sheridan   NATURE BIOTECHNOLOGY

Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis

(2014) Jamie M J Weaver et al.   NATURE GENETICS

Genetic landscape of esophageal squamous cell carcinoma

(2014) Yi-Bo Gao et al.   NATURE GENETICS

Esophageal Carcinoma

(2014) Anil K. Rustgi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Targeted Therapies in Metastatic Colorectal Cancer: A Systematic Review and Assessment of Currently Available Data

(2014) M. M. Kirstein et al.   ONCOLOGIST

Expression and clinical role of NF45 as a novel cell cycle protein in esophageal squamous cell carcinoma (ESCC)

(2014) Sujie Ni et al.   TUMOR BIOLOGY

Guidelines for Diagnosis and Treatment of Carcinoma of the Esophagus April 2012 edited by the Japan Esophageal Society

(2014) Hiroyuki Kuwano et al.   Esophagus

An alternative high output tissue microarray technique

(2013) Yuan Shi et al.   Diagnostic Pathology

Oesophageal carcinoma

(2013) Arjun Pennathur et al.   LANCET

Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial

(2013) Thomas Crosby et al.   LANCET ONCOLOGY

Amplification of the MET Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer

(2013) Alberto Bardelli et al.   Cancer Discovery

Epidermal growth factor receptor (EGFR) mutations and expression in squamous cell carcinoma of the esophagus in central Asia

(2012) Behnoush Abedi-Ardekani et al.   BMC CANCER

Alterations in epidermal growth factor receptors 1 and 2 in esophageal squamous cell carcinomas

(2012) Isabela Martins Gonzaga et al.   BMC CANCER

Characterization of the timing and prevalence of receptor tyrosine kinase expression changes in oesophageal carcinogenesis

(2012) Anna L Paterson et al.   JOURNAL OF PATHOLOGY

Prognosis of Esophageal Squamous Cell Carcinoma in Patients Positive for Human Epidermal Growth Factor Receptor Family Can Be Improved by Initial Chemotherapy with Docetaxel, Fluorouracil, and Cisplatin

(2011) Yota Yamamoto et al.   ANNALS OF SURGICAL ONCOLOGY

Cetuximab in Combination With Chemoradiotherapy Before Surgery in Patients With Resectable, Locally Advanced Esophageal Carcinoma: A Prospective, Multicenter Phase IB/II Trial (SAKK 75/06)

(2011) Thomas Ruhstaller et al.   JOURNAL OF CLINICAL ONCOLOGY

Epidermal Growth Factor Receptor (EGFR) Is Overexpressed in High-Grade Dysplasia and Adenocarcinoma of the Esophagus and May Represent a Biomarker of Histological Progression in Barrett's Esophagus (BE)

(2010) James Cronin et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Epidermal Growth Factor Receptor Protein Expression and Gene Amplification in Normal, Hyperplastic, and Cancerous Glottic Tissue: Immunohistochemical and Fluorescent in Situ Hybridization Study on Tissue Microarrays

(2009) Tamara Braut et al.   CROATIAN MEDICAL JOURNAL

Targeting MET as a strategy to overcome crosstalk-related resistance to EGFR inhibitors

(2009) Michalis V Karamouzis et al.   LANCET ONCOLOGY

Gains and Amplifications of c-myc, EGFR, and 20.q13 Loci in the No Dysplasia-Dysplasia-Adenocarcinoma Sequence of Barrett's Esophagus

(2008) A. M. Rygiel et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION